10th Febru ary,20T7

With reference above, prease find_ Unaudited

Review Report r the Financial Results along
quarter ended on sr,'
De";;;r;;r;;'t#;,*,*". with Limited
Regulation 33 of jEBI
(Listing obrigations and
oir.iJr,rr" R"q;ir"-;;ri;) with rhe
2015.
Regurations,

You are requested to

kindly take the same on
record.
Thanking you

Yours faithfully,

For Toheal

Director
DIN:01.66208s

Encl.: As above
 : Office no 812, Anand
Mangal-3, Opp Core
ho
Email: tohealpha vadi-Ahhedabad_o6l phone
-(o79)6s22772g
PLCO26244

Notes: I The above results were

vedtlAudit Conunittee and taken on record
Directors at its meeting by the Boild of
on IOth february,2016.
2 The Company has only
Reportable Business Segnent
Accouting Standard in tems of requirements of
I
3 During fhe quarter 3 st December, 20 | 6, one complamts
|
4 Previous quarter,s
have been re-grouped / re_maged
was received and afteoded
wherever necessarv.

By Order ofthe Board of

Place: Ahmedabad Directors
Date :1O\OZ2O17

Managing Director
DIN:02293998
R.O.: Office n6, g72, EI\4 LtMtrED
6orll
Mangar-3, opp core
emait'tor,..tpt'.r-mi'
rc
ajnagar club, Ambavadi,
ctrv:-LzczEoal1ggsplc'
eda bad-051 Phone -(079)6
s22i-i,2g
o
Annex of Cfause 41

-".-.;;GeFa;;

* appticabG
iiT[GG f."nrol;or,ffi
********
 TOHEAL PHARMACHEM LIMITED
R'o': olTice no' 8!2, Anand Mangal-3, opp core house, Nr. Hirabag,
Nr. Rajnagar club, Ambavadi, Ahmedabad-06
Phone -(079)65227]-29 Email: tohealpharmachem@gmail.com
CtN: 12423oGJ1 ggspLco26244

Statement of Oonso

Year to date
figures for current
period ended

Cost of naterials consnmeo

Purchas : of stock-in{radE

(f) Other ex[,enses (env item

I 0% of the t,ltal expenses
ing o rerations to be shown

Profit / (Los.;) from ordin-ry activities

finance cosls but before erceptional itEil!

Tax expense - Provision for taxation

Net Profit / (Loss) for the pefiod fi 1+

Net Profit / (Loss) after

 R'o.: oFrice no. B!2,Anand Man'a'3
d:"ttJ#:,T:ffI#i]fl"in.c.,.r,o,
Phone -(079)65221129 Email: tohealpharmachem@gmail.com
Ambavadi, Ahmedabad_o.
ctN: L2423ocJ1 gg5pLco26244

ace Value of the Share shall be

Reserve et

Diluted
See note to the financial results
-Applicabte
in the case otconsotiaaGilGG

Notes:
1. The abo'ze resurts were reviewed by Audit
committee and taken on record by the Board
of Director; at its meeting held on lOth Febn
ary,2016.
2' The conLpany has only single Reportable Business
Segment in terms of requirements of
3' During the quarter ended 3lst December,
2016, onecomplaints was received and
4' The con pany does not h.a1e any subsidiary in previous
financial year. Hence, the
company htrs not mentioned figure for consolidated
result for quarter ended on 3l/12/2016.

Place : Ahmedat,ad
Date :'10t02t2017
R'o'; office no.8t2,o..,1i-,1g1 r,
p'rone _ "JoT',.}::ffTIH,.T":XI'^1T*,.
079)65221129 Email: tohealpharmachem@gmail.com crub, Ambavadi, Ahmedabad_061
Ctw: |_Z+ZSOCj IggSpLCO26244

EOU TY AND LIABiM

received a ga inst share-warrants

Reserve@

s u b-tc,tat - Non-cuEilEEiliiE

rorAl-EO@

in the case of
tatement of assets and liabitities.
 il/sPDAtAt&co.
CI{ARTERID ACCOI/I\TIAI\TTS -\
75,sAM AST B RA M -\
rs nnrn I va- .roa,=rr,
DR. BANKER,S HOSPITAL
ROAD,
B HATTHA, PALDI,AH
M EDABAD 38 OO O
7
( 1t{) 95868161 19
( 0 l
ots_2a600561
_ e.mail ca=ldaial @yanoi,io.in

ate: ro
Limited Review Report
Review Report to Toheal pharmachem
Limited
we have reviewed
lh,1-lccomnanying statement cf standalone unaudited financial
lffi
ii,Y'':3ir'', ::T,?Y*i"T1ff?"".,n",;.'fi;"d
Board orDirer:torst,u. .
resurts cf
on 3r,, December, 2016
rhis
.".po',,*titrri"rl'0,.1L1':
our review- ro X;:ffifril-ix1!..|*'"oo-""0
Lv rD.us a report
on these financial stat#ents by the
based on

we conducted our rev:w in

accordance wit
Engagements ta'Reoia.t
ri"oran-riiiir"ru t2 the Standard on Review Engagement (sRE)2400,
"d d;;;;r;r* cr chartered Accountants
ffi
l:li"g
ll,',:llfJfi , ;[:'H,jTi :*,"",:xf' J;L'H'1h",",,i
primarilv to inquiries ;i;;;;;;,
of
to obtain mo derate
"-
isstatement. A review
is
rmancial data and thrrs o
provide less assurance procedures applied
to
and accordingl'v, we do not performed an audit
not opinron.
"G;;;;;;it
Based on our review
as above' noth
believe trr", ,rr"l"""rf"o""t"d ntion that causes us to
with applicable accounr repared in accordance
disclosed the i'i
!:: "* ; practices and policies
Obligations arr :gulation 33 cf the SEBI
Qt:tl"g D-__r -:
2015 nj"airg-rln-" "-urr",
which it is to be discrosre ro\
ts) Regulations,
material misstatement.
i.,

Place:Ahmedabad
Date: 10rh Februeury,2U7
 M/S P DALAL & CO.
CHARTERED ACCOUNTANTS ' - -
75,SAMAST BRAM KSHATRIYA SOCIETY,
-
DR. BANKER'S HOSPITAL ROAD,
+ BHATTHA,PALDl,AH M EDABAD 380007
( M) 9586816116 ( 0 ) 079-26600561
e-mail cagdalal@yahoo.co.in
Ref No. date : 10/02/2017
Limited Review Report

Review Report to Toheal Pharmachem Limited

We have reviewed the accompanying statement of consolidated unaudited financial results of

TOHEAL PHARMACHEM LIMITED for the period ended on 31~tDecember, 2016.This
statement is the responsibility of the Company's Management and has been approved by the
Board of Directors. Our responsibility is to issue a report on these financial statements based on
our review.

We conducted our review in accordance with the Standard on Review Engagement (SRE) 2400,
Engagements to Review Financial Statements issued by the Institute of Chartered Accountants of
India. This standard requires that we plan and perform the review to obtain moderate
assurance as to whether the financial statements are free of material misstatement. A review is 4
limited primarily to inquiries of company personnel and analytical procedures applied to
financial data and thus provide less assurance than an audit. We have not performed an audit
and accordingly, we do not express an audit opinion.

Based on our review conducted as above, nothing has come to our attention that causes us to
believe that the accompanying statement of unaudited financial results prepared in accordance
with applicable accounting standards and other recognized accounting practices and policies
has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI
(Listing Obligations and Disclosure Requirem 2015 including the manner in
whch it is to be disclosed, or that it contains a

For P, Dalal & Co.,

Chartered Accountants,
Place: Ahmedabad
Date: 10th February, 2017 a